Song et al. prepared biodegradable liposome nanoparticles (LPN) coupled with epidermal growth factor receptor to co-deliver docetaxel (DTX) and resveratrol (RSV) for the treatment of advanced non-small cell lung cancer.96 Sonali et al. studied a therapeutic diagnostic liposome conjugated with transferrin (DTX-QD-TPGS-Tf) for co-delivery of docetaxel (DTX) and quantum dots (QD) to brain cancer cells.97 Compared with Docel, the liposome modified by transferrin receptor shows significantly higher delivery of DTX and QD to brain cancer sites. This evidence concerns the gene EGFR and non-small cell lung carcinoma.